Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Wondering what age to start retirement planning? The earlier you begin, the better prepared you'll be for a comfortable retirement.
25,085 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
In March 2026, XRP and Ethereum trade near multi-month lows. This piece analyzes how far a $1,000 bet could grow in e...
Microsoft rolls out Copilot Health, a new module inside Copilot that links wearables, electronic health records, and ...
Exxon Mobil, Chevron and other producers climb to all-time stock valuations as geopolitical risk pushes energy prices...
Two durable energy bets stand out in 2026, blending a royalty based producer with a diversified energy fund to weathe...
Nvidia’s slip headlines a cautious mood as GTC 2026 approaches. This deep dive explores what it means for tech stocks...
Coinbase and Bybit are in early-stage talks about a strategic investment partnership that could pave the way for Bybi...
Two under-the-radar names—Albertsons and H&R Block—posted results that underscore a defensive stance for investors. B...
Oakmark Select adds to discounted stocks in Q4, signaling a shift toward durable earnings as volatility persists. Nyg...
Zoom's post-pandemic growth trajectory remains uncertain as investors weigh AI opportunities and competition. This pi...
Ethereum climbed above $2,300 in today's session but faces a tough hurdle at the $2,400 zone. This ethereum price ana...
Lenders warn that money is abundant, but in texas residential real estate the true hurdle is execution and local know...